- CIIX is pursuing the $7.2 billion legal cannabis market with hemp-based cannabidiol (CBD) products; CIIX showed a 76% year-over-year operating revenues gain in FY2017
- Dickman previously served as CFO from 2010-2016; Warren Wang, CIIX’s CEO, said Dickman will “build an infrastructure that supports long-term growth”
- CIIX has plans to launch a hemp-based line of skin care products in China by year-end 2017 and is already marketing a line of hemp-infused cannabidiol products, “OptHemp,” through its U.S. subsidiary
ChineseInvestors.com, Inc. (OTCQB: CIIX) announced in an 8K SEC filing (http://dtn.fm/Sd9Dy) that Paul Dickman has returned as its chief financial officer, effective September 25, 2017. He served earlier as CFO of the company from July 2010 through October 2016. In his new position, he remains on the company’s board of directors and, as CFO, will now also be responsible for leading CIIX’s financial operations as well as instituting the company’s financial plan and strategies.
CIIX is aggressively pursuing the $7.2 billion Legal Cannabis Market (http://dtn.fm/KTq4i) with hemp-based cannabidiol (CBD) products targeted at the global Chinese-speaking community. By the end of 2017, it plans to market a hemp-infused skin care line in China through its CBD Biotechnology Co., Ltd. subsidiary. It is already marketing its OptHemp line of hemp oil-based products through its U.S. subsidiary, ChineseHempOil.com, Inc.
CIIX’s goal is to become the primary Chinese publicly traded company offering real-time financial information on its website. It conducts research & development on cannabidiol, as well as providing global retail distribution to the Chinese-speaking community. It has an online store based in the free trade zone of Shanghai, China, and plans to open a brick-and-mortar unit in San Gabriel, California. It markets hemp-based, legalized cannabidiol and other health products as well as planning the debut of a subscription website which will have the latest news on cryptocurrencies, such as bitcoin.
CIIX’s year-over-year operating revenues grew by 76% in FY2017. The consumer market for hemp-derived cannabidiol products is projected to grow at a 55% compound annual growth rate (CAGR) from $170 million in 2016 to $1 billion within three years (http://dtn.fm/fIoH8). Consilium Global Research projects that CIIX sales will reach $14.8 million by FY2020, skyrocketing at a CAGR of nearly 100% (http://dtn.fm/d6wNC). It also projects that the global CBD industry will reach $2.1 billion in consumer sales by 2020, propelled by a CAGR of about 80%.
“We are incredibly fortunate that Paul has agreed to return as our Chief Financial Officer,” Warren Wang, founder and CEO of CIIX, stated in a news release. “We look forward to his contributions in the financial and contractual management of the Company’s growth. Moreover, Paul shares our passion for excellence, innovation and entrepreneurial thinking. I am confident that Paul will serve effectively as our CFO just as he did in the past, helping us to build an infrastructure that supports long-term growth.”
For more information, visit the company’s website at www.ChineseInvestors.com
Let us hear your thoughts: ChineseInvestors.com, Inc. Message Board
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
This post first appeared on Monaker Group, Inc. (MKGI) Carves Niche In Explosi, please read the originial post: here